DALLAS, Jan. 9, 2012 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring Arena Pharmaceuticals Inc. (Nasdaq:ARNA). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how ARNA stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for ARNA at: http://www.microstockprofit.com/lp/ARNA
This newsletter has been helping traders make great investment decisions on ARNA; click here for a 15% discount offer.
In the report, the analyst notes:
"ARNA shares were boosted earlier last week after the San Diego-based company and partner Eisai announced that the former has submitted its response to the U.S. FDA's complete response letter following review of the lorcaserin New Drug Application."
"For the third quarter ended September 30, 2011, ARNA reported total revenues of $3.46 million, compared to total revenues of $7.63 million in the comparable quarter of 2010."
To read the entire report, visit: www.microstockprofit.com/lp/ARNA
See what investors are saying about ARNA at http://www.stockhideout.com
Get breaking news on ARNA at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.